» Articles » PMID: 20236866

Thymus Transplantation

Overview
Journal Clin Immunol
Date 2010 Mar 19
PMID 20236866
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Thymus transplantation is a promising investigational therapy for infants born with no thymus. Because of the athymia, these infants lack T cell development and have a severe primary immunodeficiency. Although thymic hypoplasia or aplasia is characteristic of DiGeorge anomaly, in "complete" DiGeorge anomaly, there is no detectable thymus as determined by the absence of naive (CD45RA(+), CD62L(+)) T cells. Transplantation of postnatal allogeneic cultured thymus tissue was performed in sixty subjects with complete DiGeorge anomaly who were under the age of 2 years. Recipient survival was over 70%. Naive T cells developed 3-5 months after transplantation. The graft recipients were able to discontinue antibiotic prophylaxis, and immunoglobulin replacement. Immunosuppression was used in a subset of subjects but was discontinued when naive T cells developed. The adverse events have been acceptable with thyroid disease being the most common. Research continues on mechanisms underlying immune reconstitution after thymus transplantation.

Citing Articles

Transcriptomic profiling of thymic dysregulation and viral tropism after neonatal roseolovirus infection.

Belean A, Xue E, Cisneros B, Roberson E, Paley M, Bigley T Front Immunol. 2024; 15:1375508.

PMID: 38895117 PMC: 11183875. DOI: 10.3389/fimmu.2024.1375508.


Improving thymus implantation for congenital athymia with interleukin-7.

Min H, Valente L, Xu L, ONeil S, Begg L, Kurtzberg J Clin Transl Immunology. 2023; 12(11):e1475.

PMID: 38020730 PMC: 10665642. DOI: 10.1002/cti2.1475.


Comparison of Elicitation Approaches in Early Stage HTA Applied on Artificial Thymus for Patients with DiGeorge Syndrome.

Gorelova M, Rysankova K, Donin G, Kneppo P, Rogalewicz V Healthcare (Basel). 2023; 11(22).

PMID: 37998494 PMC: 10671534. DOI: 10.3390/healthcare11223002.


Omenn syndrome in a 10-month-old male with athymia and VACTERL association.

Pangli B, Braddock S, Knutsen A J Allergy Clin Immunol Glob. 2023; 2(4):100153.

PMID: 37781660 PMC: 10509858. DOI: 10.1016/j.jacig.2023.100153.


A model for preservation of thymocyte-depleted thymus.

Dias A, Damaceno-Rodrigues N, Gimenez T, Oliveira P, Zerbini M, Carneiro-Sampaio M Braz J Med Biol Res. 2023; 56:e12647.

PMID: 37585915 PMC: 10427159. DOI: 10.1590/1414-431X2023e12647.


References
1.
Conley M, Beckwith J, Mancer J, TENCKHOFF L . The spectrum of the DiGeorge syndrome. J Pediatr. 1979; 94(6):883-90. DOI: 10.1016/s0022-3476(79)80207-3. View

2.
Rope A, Cragun D, Saal H, Hopkin R . DiGeorge anomaly in the absence of chromosome 22q11.2 deletion. J Pediatr. 2009; 155(4):560-5. DOI: 10.1016/j.jpeds.2009.04.010. View

3.
Reece E, Gartner J, Seemayer T, Joncas J, Pagano J . Epstein-Barr virus in a malignant lymphoproliferative disorder of B-cells occurring after thymic epithelial transplantation for combined immunodeficiency. Cancer Res. 1981; 41(11 Pt 1):4243-7. View

4.
Dictor M, Fasth A, Olling S . Abnormal B-cell proliferation associated with combined immunodeficiency, cytomegalovirus, and cultured thymus grafts. Am J Clin Pathol. 1984; 82(4):487-90. DOI: 10.1093/ajcp/82.4.487. View

5.
YOW M, White N, Taber L, Frank A, Gruber W, May R . Acquisition of cytomegalovirus infection from birth to 10 years: a longitudinal serologic study. J Pediatr. 1987; 110(1):37-42. DOI: 10.1016/s0022-3476(87)80284-6. View